Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Core Scientific Secures $500M Commitment from JPMorgan Chase, Doubles Financing Facility to $1B

Core Scientific expanded its strategic financing facility to $1.0 billion after securing an additional $500 million commitment from JPMorgan Chase Bank under the accordion feature of its 364-day credit facility.

The new commitment doubles the size of the facility from the previously announced $500 million backing from Morgan Stanley alone. With both commitments in place, Core Scientific now has $1.0 billion of total funded commitments available.

Borrowings under the facility will carry interest at SOFR plus 250 basis points, or 2.50%.

The company said it plans to use proceeds for general corporate purposes tied to data center development, including equipment purchases, pre-development costs, real estate acquisitions, and securing additional energy for data centers.

Core Scientific said the expanded financing gives it more capital to push ahead with its development and go-to-market strategy as it works to accelerate infrastructure delivery. Following these announcements, the company's shares moved 4.48%, and are now trading at a price of $18.89. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS